The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Leqembi (lecanemab) to treat mild cognitive impairment and early Alzheimer’s disease, following a re-examination of the clinical data. The recommendation is only for patients who have one or no copies of the apolipoprotein E4 (APOE4) gene
Read More
Victor Wembanyama must try to find his stride without Gregg Popovich The Washington PostSpurs head coach Gregg Popovich out indefinitely after weekend health issue Yahoo SportsSpurs coach Gregg Popovich to miss time because of undisclosed illness nba.comSpurs aim to play for ailing Popovich San Antonio Express-NewsWhat We Learned from the Spurs’ Win Over the Timberwolves Pounding The Rock…
Read More
“She has over $70,000 in her retirement fund, but says that’s for emergencies.”…
Read More
Recent Comments